Tag: INDIAN PHARMA NEWS
AstraZeneca’s Ultomiris®️ Cuts Proteinuria by 43.4% in Phase – 3 Trial
Alexion, AstraZeneca Rare Disease, announced positive results from a prespecified interim analysis of the global Phase III I CAN trial. The data demonstrate...
Drug Control Raid in Howrah: Large Stock of Medicines Seized, Samples Sent for Testing
A multi-day operation by the Drug Control Department in Howrah has led to the seizure of a large quantity of medicines from a godown...
Lupin Gets U.S. FDA Approval for Ranluspec™ to Treat Retinal Disorders
Lupin Limited has secured U.S. FDA approval for Ranluspec™ (ranibizumab-hkdz), an interchangeable biosimilar to Genentech’s Lucentis® — a milestone that reshapes patient access to sight-saving biologics across...
Glenmark Launches Generic Vimpat®️ Injection in the US to Expand Injectable Portfolio
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of its Lacosamide Injection USP, 200mg/mL,20mg/mL, 10mg/mL available in Single-Dose Vials, as detailed in the official...
Telangana & South Africa Forge Strategic Alliance in Pharma, Medical Tourism, and ‘Bharat Future City
Telangana Chief Minister A Revanth Reddy hosted a high-level bilateral meeting with a South African delegation led by Deputy President Paul Mashatile to expand...
24 Nations, One Standard — India’s Pharmacopoeia Goes Global
The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding with Lao PDR's Food and Drug Department and Ministry of Health, marking a...